Hydrogen gas presents a promising therapeutic strategy for sepsis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Xie, Keliang ^a,b   Liu, Lingling ^a,b   Yu, Yonghao ^a,b   Wang, Guolin ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Research Institute of Anesthesiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN; SODIUM CHLORIDE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CLINICAL TRIAL (TOPIC); HUMAN; NONHUMAN; OXIDATIVE STRESS; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; THERAPY EFFECT; ANIMAL;

ANIMALS; HUMANS; HYDROGEN; SEPSIS; SODIUM CHLORIDE;

EID: 84900010693     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/807635     Document Type: Review

References (102)

1. Briegel J., Mohnle P., International guidelines of the Surviving Sepsis Campaign: update 2012. Der Anaesthesist 2013 62 4 304 309 10.1007/s00101-013- 2158-x
2. Mayr F. B., Yende S., Angus D. C., Epidemiology of severe sepsis. Virulence 2014 5 1 4 11
3. Okazaki Y., Matsukawa A., Pathophysiology of sepsis and recent patents on the diagnosis, treatment and prophylaxis for sepsis. Recent Patents on Inflammation and Allergy Drug Discovery 2009 3 1 26 32 2-s2.0-61449149742 10.2174/187221309787158416
4. Martin G. S., Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes. Expert Review of Anti-Infective Therapy 2012 10 6 701 706 10.1586/eri.12.50
5. Perner A., Haase N., Guttormsen A. B., Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. The New England Journal of Medicine 2012 367 2 124 134 10.1056/NEJMoa1204242
6. Martin G. S., Mannino D. M., Eaton S., Moss M., The epidemiology of sepsis in the United States from 1979 through 2000. The New England Journal of Medicine 2003 348 16 1546 1554 2-s2.0-0037451929 10.1056/NEJMoa022139
7. Russell J. A., Management of sepsis. The New England Journal of Medicine 2006 355 16 1699 1713 2-s2.0-33750047495 10.1056/NEJMra043632
8. Cheng B., Xie G., Yao S., Wu X., Guo Q., Gu M., Fang Q., Xu Q., Wang D., Jin Y., Yuan S., Wang J., Du Z., Sun Y., Fang X., Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Critical Care Medicine 2007 35 11 2538 2546 2-s2.0-39049165161 10.1097/01.CCM.0000284492.30800.00
9. Nguyen H. B., Smith D., Sepsis in the 21st century: recent definitions and therapeutic advances. American Journal of Emergency Medicine 2007 25 5 564 571 2-s2.0-34249290789 10.1016/j.ajem.2006.08.015
10. Hotchkiss R. S., Karl I. E., The pathophysiology and treatment of sepsis. The New England Journal of Medicine 2003 348 2 138 150 2-s2.0-0037426726 10.1056/NEJMra021333
11. Eichacker P. Q., Natanson C., Danner R. L., Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly. The New England Journal of Medicine 2006 355 16 1640 1642 2-s2.0-33750066637 10.1056/NEJMp068197
12. Oba Y., Iwata K., Treatment of neonatal sepsis with immune globulin. The New England Journal of Medicine 2012 366 1 91 2-s2.0-84855752177 10.1056/NEJMc1112575
13. Lee W. L., Slutsky A. S., Sepsis and endothelial permeability. The New England Journal of Medicine 2010 363 7 689 691 2-s2.0-77956635947 10.1056/NEJMcibr1007320
14. Abraham E., Laterre P.-F., Garg R., Levy H., Talwar D., Trzaskoma B. L., François B., Guy J. S., Brückmann M., Rea-Neto Á., Rossaint R., Perrotin D., Sablotzki A., Arkins N., Utterback B. G., Macias W. L., Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. The New England Journal of Medicine 2005 353 13 1332 1341 2-s2.0-25444492831 10.1056/NEJMoa050935
15. Hotchkiss R. S., Monneret G., Payen D., Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. The Lancet Infectious Diseases 2013 13 3 260 268 10.1016/S1473-3099(13)70001-X
16. Xie K., Yu Y., Zhang Z., Liu W., Pei Y., Xiong L., Hou L., Wang G., Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock 2010 34 5 495 501 2-s2.0-78149282656 10.1097/SHK.0b013e3181def9aa
17. Mu J., Xie K., Hou L., Peng D., Shang L., Ji G., Li J., Lu Y., Xiong L., Subanesthetic dose of isoflurane protects against zymosan-induced generalized inflammation and its associated acute lung injury in mice. Shock 2010 34 2 183 189 2-s2.0-77955011266 10.1097/SHK.0b013e3181cffc3f
18. Hou L., Xie K., Li N., Qin M., Lu Y., Ma S., Ji G., Xiong L., 100% oxygen inhalation protects against zymosan-induced sterile sepsis in mice: the roles of inflammatory cytokines and antioxidant enzymes. Shock 2009 32 4 451 460 2-s2.0-70349679098 10.1097/SHK.0b013e31819c391a
19. Chung L. P., Waterer G. W., Genetic predisposition to respiratory infection and sepsis. Critical Reviews in Clinical Laboratory Sciences 2011 48 5-6 250 268 2-s2.0-84055182880 10.3109/10408363.2011.641517
20. Stehr S. N., Reinhart K., Sepsis as a global health problem-why we need a global sepsis alliance. Shock 2013 39 supplement 1 3 4 10.1097/SHK. 0b013e31828fad61
21. Dellinger R. P., Levy M. M., Rhodes A., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Medicine 2013 39 2 165 228
22. Brocklehurst P., Farrell B., King A., Juszczak E., Darlow B., Haque K., Salt A., Stenson B., TarnowMordi W., Treatment of neonatal sepsis with intravenous immune globulin. The New England Journal of Medicine 2011 365 13 1201 1211 2-s2.0-80053367664 10.1056/NEJMoa1100441
23. Mackenzie A., Activated protein C for sepsis. The New England Journal of Medicine 2010 362 12 1150 1151 2-s2.0-77950197710
24. Dole M., Wilson F. R., Fife W. P., Hyperbaric hydrogen therapy: a possible treatment for cancer. Science 1975 190 4210 152 154 2-s2.0-0016743840
25. Shirahata S., Kabayama S., Nakano M., Miura T., Kusumoto K., Gotoh M., Hayashi H., Otsubo K., Morisawa S., Katakura Y., Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage. Biochemical and Biophysical Research Communications 1997 234 1 269 274 2-s2.0-0344700062 10.1006/bbrc.1997.6622
26. Fontanari P., Badier M., Guillot C., Tomei C., Burnet H., Gardette B., Jammes Y., Changes in maximal performance of inspiratory and skeletal muscles during and after the 7.1-MPa hydra 10 record human dive. European Journal of Applied Physiology 2000 81 4 325 328 2-s2.0-0034085997
27. Gharib B., Hanna S., Abdallahi O. M. S., Lepidi H., Gardette B., de Reggi M., Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation. Comptes Rendus de l'Academie des Sciences III 2001 324 8 719 724 2-s2.0-0034890442 10.1016/S0764-4469(01)01350-6
28. Ohsawa I., Ishikawa M., Takahashi K., Watanabe M., Nishimaki K., Yamagata K., Katsura K.-I., Katayama Y., Asoh S., Ohta S., Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature Medicine 2007 13 6 688 694 2-s2.0-34250021071 10.1038/nm1577
29. Xie K., Yu Y., Huang Y., Zheng L., Li J., Chen H., Han H., Hou L., Gong G., Wang G., Molecular hydrogen ameliorates lipopolysaccharide-induced acute lung injury in mice through reducing inflammation and apoptosis. Shock 2012 37 5 548 555 2-s2.0-84859903016 10.1097/SHK.0b013e31824ddc81
30. Xie K., Yu Y., Pei Y., Hou L., Chen S., Xiong L., Wang G., Protective effects of hydrogen gas on murine polymicrobial sepsis via reducing oxidative stress and HMGB1 release. Shock 2010 34 1 90 97 2-s2.0-77953903866 10.1097/SHK.0b013e3181cdc4ae
31. Hayashida K., Sano M., Ohsawa I., Shinmura K., Tamaki K., Kimura K., Endo J., Katayama T., Kawamura A., Kohsaka S., Makino S., Ohta S., Ogawa S., Fukuda K., Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochemical and Biophysical Research Communications 2008 373 1 30 35 2-s2.0-45949085302 10.1016/j.bbrc.2008.05.165
32. Fukuda K.-I., Asoh S., Ishikawa M., Yamamoto Y., Ohsawa I., Ohta S., Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochemical and Biophysical Research Communications 2007 361 3 670 674 2-s2.0-34547768785 10.1016/j.bbrc.2007.07.088
33. Xiang L., Tan J. W., Huang L. J., Inhalation of hydrogen gas reduces liver injury during major hepatotectomy in swine. World Journal of Gastroenterology 2012 18 37 5197 5204 10.3748/wjg.v18.i37.5197
34. Hayashi T., Yoshioka T., Hasegawa K., Miyamura M., Mori T., Ukimura A., Matsumura Y., Ishizaka N., Inhalation of hydrogen gas attenuates left ventricular remodeling induced by intermittent hypoxia in mice. American Journal of Physiology: Heart and Circulatory Physiology 2011 301 3 H1062 H1069 2-s2.0-80052324626 10.1152/ajpheart.00150.2011
35. Zheng J., Liu K., Kang Z., Cai J., Liu W., Xu W., Li R., Tao H., Zhang J. H., Sun X., Saturated hydrogen saline protects the lung against oxygen toxicity. Undersea and Hyperbaric Medicine 2010 37 3 185 192 2-s2.0-77954267423
36. Buchholz B. M., Kaczorowski D. J., Sugimoto R., Yang R., Wang Y., Billiar T. R., McCurry K. R., Bauer A. J., Nakao A., Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. American Journal of Transplantation 2008 8 10 2015 2024 2-s2.0-51849085219 10.1111/j.1600-6143.2008.02359.x
37. Kajiyama S., Hasegawa G., Asano M., Hosoda H., Fukui M., Nakamura N., Kitawaki J., Imai S., Nakano K., Ohta M., Adachi T., Obayashi H., Yoshikawa T., Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutrition Research 2008 28 3 137 143 2-s2.0-41349120002 10.1016/j.nutres.2008.01.008
38. Fu Y., Ito M., Fujita Y., Ito M., Ichihara M., Masuda A., Suzuki Y., Maesawa S., Kajita Y., Hirayama M., Ohsawa I., Ohta S., Ohno K., Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neuroscience Letters 2009 453 2 81 85 2-s2.0-61449159621 10.1016/j.neulet.2009.02.016
39. Cai J., Kang Z., Liu K., Liu W., Li R., Zhang J. H., Luo X., Sun X., Neuroprotective effects of hydrogen saline in neonatal hypoxia-ischemia rat model. Brain Research 2009 1256 129 137 2-s2.0-59649110496 10.1016/j.brainres. 2008.11.048
40. Ji X., Liu W., Xie K., Liu W., Qu Y., Chao X., Chen T., Zhou J., Fei Z., Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress. Brain Research 2010 1354 196 205 2-s2.0-77956399025 10.1016/j.brainres.2010.07.038
41. Xie K., Fu W., Xing W., Combination therapy with molecular hydrogen and hyperoxia in a murine model of polymicrobial sepsis. Shock 2012 38 6 656 663
42. Liu W., Shan L. P., Dong X. S., Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury. World Journal of Gastroenterology 2013 19 4 492 502 10.3748/wjg.v19.i4.492
43. Chen H. G., Xie K. L., Han H. Z., Heme oxygenase-1 mediates the anti-inflammatory effect of molecular hydrogen in LPS-stimulated RAW 264.7 macrophages. International Journal of Surgery 2013 11 10 1060 1066 10.1016/j.ijsu.2013.10.007
44. Xie K., Therapeutic effects of hydrogen-rich saline on peritonitis-induced septic shock in rats. pp. 148-149, 2013
45. Li G. M., Ji M. H., Sun X. J., Effects of hydrogen-rich saline treatment on polymicrobial sepsis. Journal of Surgical Research 2013 181 2 279 286 10.1016/j.jss.2012.06.058
46. Xie K., Yu Y., Hou L., Chen H., Han H., Xiong L., Wang G., Nrf2 is critical in the protective role of hydrogen gas against murine polymicrobial sepsis. British Journal of Anaesthesia 2012 108 3 538 539
47. Xie K.-L., Hou L.-C., Wang G.-L., Xiong L.-Z., Effects of hydrogen gas inhalation on serum high mobility group box 1 levels in severe septic mice. Zhejiang da Xue Xue Bao. Yi Xue Ban 2010 39 5 454 457 2-s2.0-79955668098
48. Matsuda A., Jacob A., Wu R., Aziz M., Yang W.-L., Matsutani T., Suzuki H., Furukawa K., Uchida E., Wang P., Novel therapeutic targets for sepsis: regulation of exaggerated inflammatory responses. Journal of Nippon Medical School 2012 79 1 4 18 2-s2.0-84856854603 10.1272/jnms.79.4
49. Beasley D., Schwartz J. H., Brenner B. M., Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. The Journal of Clinical Investigation 1991 87 2 602 608 2-s2.0-0025973551
50. Chapman P. B., Lester T. J., Casper E. S., Gabrilove J. L., Wong G. Y., Kempin S. J., Gold P. J., Welt S., Warren R. S., Starnes H. F., Sherwin S. A., Old L. J., Oettgen H. F., Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. Journal of Clinical Oncology 1987 5 12 1942 1951 2-s2.0-0023472191
51. Dinarello C. A., Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 1997 112 supplement 6 321S 329S 2-s2.0-0031452476
52. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., DInarello C. A., Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. The Journal of Clinical Investigation 1988 81 4 1162 1172 2-s2.0-0344140225
53. Cai B., Deitch E. A., Ulloa L., Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators of Inflammation 2010 2010 10 2-s2.0-77954558483 10.1155/2010/642462 642462
54. Riedemann N. C., Ward P. A., Anti-inflammatory strategies for the treatment of sepsis. Expert Opinion on Biological Therapy 2003 3 2 339 350 2-s2.0-0037391676 10.1517/14712598.3.2.339
55. Mira J.-P., Cariou A., Grall F., Delclaux C., Losser M.-R., Heshmati F., Cheval C., Monchi M., Teboul J.-L., Riché F., Leleu G., Arbibe L., Mignon A., Delpech M., Dhainaut J.-F., Association of TNF2, a TNF- promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. The Journal of the American Medical Association 1999 282 6 561 568 2-s2.0-0033546610 10.1001/jama.282.6.561
56. van der Poll T., Lowry S. F., Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 1995 3 1 1 12 2-s2.0-0029192212
57. Moshage H., Cytokines and the hepatic acute phase response. The Journal of Pathology 1997 181 3 257 266
58. Kast R. E., Tumor necrosis factor has positive and negative self regulatory feed back cycles centered around cAMP. International Journal of Immunopharmacology 2000 22 11 1001 1006 2-s2.0-0033768769 10.1016/S0192-0561(00) 00046-1
59. Andersson U., Tracey K. J., HMGB1 in sepsis. Scandinavian Journal of Infectious Diseases 2003 35 9 577 584 2-s2.0-0242288518 10.1080/ 00365540310016286
60. Nogueira-Machado J. A., de Oliveira V. C., HMGB-1 as a target for inflammation controlling. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 2012 6 3 201 209 10.2174/187221412802481784
61. Yang H., Tracey K. J., Targeting HMGB1 in inflammation. Biochimica et Biophysica Acta 2010 1799 1-2 149 156 2-s2.0-74449089862 10.1016/j.bbagrm.2009. 11.019
62. Bae J. S., Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Archives of Pharmacal Research 2012 35 9 1511 1523 10.1007/s12272-012-0901-5
63. Huang W., Tang Y., Li L., HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010 51 2 119 126 2-s2.0-77954175102 10.1016/j.cyto.2010.02.021
64. Karlsson S., Pettilä V., Tenhunen J., Laru-Sompa R., Hynninen M., Ruokonen E., HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis. Intensive Care Medicine 2008 34 6 1046 1053 2-s2.0-46149118623 10.1007/s00134-008-1032-9
65. Fung A., Vizcaychipi M., Lloyd D., Wan Y., Ma D., Central nervous system inflammation in disease related conditions: mechanistic prospects. Brain Research 2012 1446 144 155 2-s2.0-84858451996 10.1016/j.brainres.2012.01.061
66. Granger J. I., Ratti P. L., Datta S. C., Sepsis-induced morbidity in mice: effects on body temperature, body weight, cage activity, social behavior and cytokines in brain. Psychoneuroendocrinology 2013 38 7 1047 1057 10.1016/j.psyneuen.2012.10.010
67. Comim C. M., Vilela M. C., Constantino L. S., Petronilho F., Vuolo F., Lacerda-Queiroz N., Rodrigues D. H., da Rocha J. L., Teixeira A. L., Quevedo J., dal-Pizzol F., Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Medicine 2011 37 4 711 718 2-s2.0-79953823966 10.1007/s00134-011-2151-2
68. Laird M. D., Shields J. S., Sukumari-Ramesh S., High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 2014 62 1 26 38 10.1002/glia.22581
69. Petit-Bertron A.-F., Fitting C., Cavaillon J.-M., Adib-Conquy M., Adherence influences monocyte responsiveness to interleukin-10. Journal of Leukocyte Biology 2003 73 1 145 154 2-s2.0-0037239245 10.1189/jlb.0802388
70. Sies H., Cadenas E., Oxidative stress: damage to intact cells and organs. Philosophical Transactions of the Royal Society of London B: Biological sciences 1985 311 1152 617 631 2-s2.0-0022428152
71. Sheu S.-S., Nauduri D., Anders M. W., Targeting antioxidants to mitochondria: a new therapeutic direction. Biochimica et Biophysica Acta 2006 1762 2 256 265 2-s2.0-29344446328 10.1016/j.bbadis.2005.10.007
72. Turrens J. F., Mitochondrial formation of reactive oxygen species. The Journal of Physiology 2003 552 2 335 344 2-s2.0-0142150051 10.1113/jphysiol. 2003.049478
73. Carr A. C., McCall M. R., Frei B., Oxidation of LDL by myeloperoxidase and reactive nitrogen species: reaction pathways and antioxidant protection. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 7 1716 1723 2-s2.0-0033927959
74. Szabó C., Ischiropoulos H., Radi R., Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nature Reviews Drug Discovery 2007 6 8 662 680 2-s2.0-34547673497 10.1038/nrd2222
75. Liaw W.-J., Chen T.-H., Lai Z.-Z., Chen S.-J., Chen A., Tzao C., Wu J.-Y., Wu C.-C., Effects of a membrane-permeable radical scavenger, tempol, on intraperitoneal sepsis-induced organ injury in rats. Shock 2005 23 1 88 96 2-s2.0-11444252498 10.1097/01.shk.0000145937.70085.89
76. Ohta S., Hydrogen gas and hydrogen water act as a therapeutic and preventive antioxidant with a novel concept. Nihon Ronen Igakkai Zasshi 2008 45 4 355 362 2-s2.0-51149106082
77. Cai J., Kang Z., Liu W. W., Luo X., Qiang S., Zhang J. H., Ohta S., Sun X., Xu W., Tao H., Li R., Hydrogen therapy reduces apoptosis in neonatal hypoxia-ischemia rat model. Neuroscience Letters 2008 441 2 167 172 2-s2.0-46749107977 10.1016/j.neulet.2008.05.077
78. Mao Y.-F., Zheng X.-F., Cai J.-M., You X.-M., Deng X.-M., Zhang J. H., Jiang L., Sun X.-J., Hydrogen-rich saline reduces lung injury induced by intestinal ischemia/reperfusion in rats. Biochemical and Biophysical Research Communications 2009 381 4 602 605 2-s2.0-62649115060 10.1016/j.bbrc.2009.02.105
79. Biswal S., Remick D. G., Sepsis: redox mechanisms and therapeutic opportunities. Antioxidants & Redox Signaling 2007 9 11 1959 1961 2-s2.0-35448970172 10.1089/ars.2007.1808
80. Nunomura A., Moreira P. I., Lee H. G., Zhu X., Castellani R. J., Smith M. A., Perry G., Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS & Neurological Disorders-Drug Targets 2007 6 6 411 423 2-s2.0-41749088686 10.2174/187152707783399201
81. Hoetzenecker W., Echtenacher B., Guenova E., Hoetzenecker K., Woelbing F., Brück J., Teske A., Valtcheva N., Fuchs K., Kneilling M., Park J.-H., Kim K.-H., Kim K.-W., Hoffmann P., Krenn C., Hai T., Ghoreschi K., Biedermann T., Röcken M., ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nature Medicine 2012 18 1 128 134 2-s2.0-84855548457 10.1038/nm.2557
82. Hengartner M. O., The biochemistry of apoptosis. Nature 2000 407 6805 770 776 2-s2.0-0034641918 10.1038/35037710
83. Chandra J., Samali A., Orrenius S., Triggering and modulation of apoptosis by oxidative stress. Free Radical Biology and Medicine 2000 29 3-4 323 333 2-s2.0-0033805296 10.1016/S0891-5849(00)00302-6
84. Xiang L., Tan J. W., Huang L. J., Inhalation of hydrogen gas reduces liver injury during major hepatotectomy in swine. World Journal of Gastroenterology 2012 18 37 5197 5204 10.3748/wjg.v18.i37.5197
85. 2 mediates cardioprotection via involvements of K ATP channels and permeability transition pores of mitochondria in dogs. Cardiovascular Drugs and Therapy 2012 26 3 217 226 10.1007/s10557-012-6381-5
86. Wang W., Tian L., Li Y., Effects of hydrogen-rich saline on rats with acute carbon monoxide poisoning. The Journal of Emergency Medicine 2013 44 1 107 115 10.1016/j.jemermed.2012.01.065
87. Hoesel B., Schmid J. A., The complexity of NF- B signaling in inflammation and cancer. Molecular Cancer 2013 12, article 86 10.1186/1476-4598-12-86
88. Morgan M. J., Liu Z.-G., Crosstalk of reactive oxygen species and NF- B signaling. Cell Research 2011 21 1 103 115 2-s2.0-78650894319 10.1038/cr.2010.178
89. Zhuang Z., Sun X. J., Zhang X., Nuclear factor- B/Bcl-XL pathway is involved in the protective effect of hydrogen-rich saline on the brain following experimental subarachnoid hemorrhage in rabbits. Journal of Neuroscience Research 2013 91 12 1599 1608 10.1002/jnr.23281
90. Huang C.-S., Kawamura T., Peng X., Tochigi N., Shigemura N., Billiar T. R., Nakao A., Toyoda Y., Hydrogen inhalation reduced epithelial apoptosis in ventilator-induced lung injury via a mechanism involving nuclear factor- B activation. Biochemical and Biophysical Research Communications 2011 408 2 253 258 2-s2.0-79955665169 10.1016/j.bbrc.2011.04.008
91. 2 inhibits TNF- induced lectin-like oxidized LDL receptor-1 expression by inhibiting nuclear factor B activation in endothelial cells. Biotechnology Letters 2011 33 9 1715 1722 2-s2.0-80051470238 10.1007/s10529-011-0630-8
92. Kobayashi M., Yamamoto M., Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants & Redox Signaling 2005 7 3-4 385 394 2-s2.0-14044254798 10.1089/ars.2005.7.385
93. Satoh T., Okamoto S.-I., Cui J., Watanabe Y., Furuta K., Suzuki M., Tohyama K., Lipton S. A., Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phase II inducers. Proceedings of the National Academy of Sciences of the United States of America 2006 103 3 768 773 2-s2.0-31444447800 10.1073/pnas.0505723102
94. Thimmulappa R. K., Lee H., Rangasamy T., Reddy S. P., Yamamoto M., Kensler T. W., Biswal S., Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. The Journal of Clinical Investigation 2006 116 4 984 995 2-s2.0-33645530745 10.1172/JCI25790
95. Chung S. W., Liu X., Macias A. A., Baron R. M., Perrella M. A., Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. The Journal of Clinical Investigation 2008 118 1 239 247 2-s2.0-38149008232 10.1172/JCI32730
96. Kawamura T., Wakabayashi N., Shigemura N., Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo. American Journal of Physiology: Lung Cellular and Molecular Physiology 2013 304 10 L646 L656 10.1152/ajplung.00164. 2012
97. Shih A. Y., Johnson D. A., Wong G., Kraft A. D., Jiang L., Erb H., Johnson J. A., Murphy T. H., Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. The Journal of Neuroscience 2003 23 8 3394 3406 2-s2.0-0037996661
98. Zheng X., Mao Y., Cai J., Li Y., Liu W., Sun P., Zhang J. H., Sun X., Yuan H., Hydrogen-rich saline protects against intestinal ischemia/reperfusion injury in rats. Free Radical Research 2009 43 5 478 484 2-s2.0-67650104056 10.1080/10715760902870603
99. Chen C., Chen Q., Mao Y., Xu S., Xia C., Shi X., Zhang J. H., Yuan H., Sun X., Hydrogen-rich saline protects against spinal cord injury in rats. Neurochemical Research 2010 35 7 1111 1118 2-s2.0-77953229191 10.1007/s11064-010-0162-y
100. Wang C., Li J., Liu Q., Yang R., Zhang J. H., Cao Y.-P., Sun X.-J., Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF- B activation in a rat model of amyloid-beta-induced Alzheimer's disease. Neuroscience Letters 2011 491 2 127 132 2-s2.0-79951576829 10.1016/j.neulet.2011.01.022
101. Zhou J., Chen Y., Huang G.-Q., Li J., Wu G.-M., Liu L., Bai Y.-P., Wang J., Hydrogen-rich saline reverses oxidative stress, cognitive impairment, and mortality in rats submitted to sepsis by cecal ligation and puncture. Journal of Surgical Research 2012 178 1 390 400 2-s2.0-84859190296 10.1016/j.jss.2012.01. 041
102. James A. M., Cochemé H. M., Murphy M. P., Mitochondria-targeted redox probes as tools in the study of oxidative damage and ageing. Mechanisms of Ageing and Development 2005 126 9 982 986 2-s2.0-22744448180 10.1016/j.mad.2005.03.026